Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
23.49
+0.14 (0.60%)
At close: May 4, 2026, 4:00 PM EDT
23.70
+0.21 (0.89%)
Pre-market: May 5, 2026, 7:50 AM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $2.94 billion as of May 5, 2026. Its market cap has increased by 90.35% in one year.
Market Cap
2.94B
Enterprise Value
2.83B
1-Year Change
90.35%
Ranking
Category
Stock Price
$23.49
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $2.94B, an increase of 275.68%. That is a compound annual growth rate of 23.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 2.94B | -17.41% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 3.25B |
| Alumis | 3.21B |
| Erasca | 3.15B |
| Structure Therapeutics | 3.06B |
| Beam Therapeutics | 3.01B |
| Denali Therapeutics | 2.96B |
| Nektar Therapeutics | 2.93B |
| Dyne Therapeutics | 2.93B |